PF-Atlas › Mechanisms › LPA1 receptor antagonist — blocks lysophosphatidic acid pro-fibrotic signaling
LPA1 receptor antagonist — blocks lysophosphatidic acid pro-fibrotic signaling in IPF
Mechanism of action · idiopathic pulmonary fibrosis
Overview
LPA1 receptor antagonist — blocks lysophosphatidic acid pro-fibrotic signaling is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 0 clinical trials acting through this mechanism.
Drugs targeting LPA1 receptor antagonist — blocks lysophosphatidic acid pro-fibrotic signaling
Therapies
Medical disclaimer. This is a research summary, not medical advice.